Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34−0.03 (-2.19%)
Close on Nov 18, 2026Market cap $4.89MP/E –Yield –
Pulmatrix operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Pulmatrix's operating income for the twelve months ending Sep 30, 2026 was -$4.47M. For fiscal 2025 it was -$5.17M. The highest annual figure on record is -$5.17M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.17M | – |
| FY2024 | Dec 31, 2024 | -$9.76M | – |
| FY2023 | Dec 31, 2023 | -$14.74M | – |
| FY2022 | Dec 31, 2022 | -$18.95M | – |
| FY2021 | Dec 31, 2021 | -$20.17M | – |
| FY2020 | Dec 31, 2020 | -$9.86M | – |
| FY2019 | Dec 31, 2019 | -$20.69M | – |
| FY2018 | Dec 31, 2018 | -$20.40M | – |
| FY2017 | Dec 31, 2017 | -$17.48M | – |
| FY2016 | Dec 31, 2016 | -$24.87M | – |
| FY2015 | Dec 31, 2015 | -$23.02M | – |
| FY2014 | Dec 31, 2014 | -$9.08M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.22M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.05M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.29M | – |
| Q4 FY2025 | Dec 31, 2025 | -$908.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$866.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.55M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.85M | -347.3% |
| Q4 FY2024 | Dec 31, 2024 | -$1.95M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.66M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.90M | – |
| Q1 FY2024 | Mar 31, 2024 | $747.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.23M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.99M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.33M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.56M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.96M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.04M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.19M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.67M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.11M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.68M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.95M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.96M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.11M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.83M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.13M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.11M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.43M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.30M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.43M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.31M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.46M | – |
See a number that looks wrong?